Ginkgo Bioworks Holdings, Inc. Share Price & Technical Analysis
DNA · $8.41 (+4.08%)
Healthcare / Biotechnology
$8.41
+4.08%
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artifici…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-3% return in May, -6% avg return in past 3 year May month.
11% return in 2026, -15% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 6% | -23% | -6% | 37% | -3% | – | – | – | – | – | – | – | 11% |
| 25 | 34% | -34% | -32% | 30% | -8% | 60% | 19% | 2% | 21% | -10% | -28% | -7% | 47% |
| 24 | -27% | 23% | -9% | -25% | -40% | -37% | 12% | -56% | 23% | -6% | 13% | 11% | -119% |
| 23 | 15% | -24% | -8% | -8% | 30% | 17% | 33% | -4% | -23% | -24% | -6% | 31% | 28% |
| 22 | -29% | -25% | -11% | -29% | 6% | -23% | 19% | -4% | 18% | -16% | -29% | -14% | -136% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$549.38M
P/E ratio
—
52W high
$17.58
52W low
$5.37
Volume
8,68,803
Beta
1.78
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Ginkgo Bioworks Holdings, Inc. share price today?
- Ginkgo Bioworks Holdings, Inc. (DNA) last traded around $8.41 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DNA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DNA. Download the app for real-time alerts.
- How can I analyze Ginkgo Bioworks Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.